Trial Profile
Immune Evaluation Study of Sipuleucel-T in African American and Non African American Men with Castrate Resistant Prostate Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2014
Price :
$35
*
At a glance
- Drugs Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- Acronyms PCCTC
- 01 Nov 2014 New trial record